ArticleActa neurochirurgica2026
A markerless, real-time, augmented reality-based surgical navigation system for neurosurgical biopsies.
Article in Acta neurochirurgica, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
purposeNeurosurgical biopsies require high accuracy and precision and are executed with image-guided surgical navigation. The current state-of-the-art techniques require markers, are displayed on a 2D screen, and have a time-consuming setup. We propose an AR-driven surgical navigation method that automatically projects a 3D virtual overlay onto a patient in real-time, without the use of any markers.
methodBaseline accuracy of the proposed system and the StealthStation S8 was measured on a 3D printed human head phantom in a lab-based setting. For the measurements in the operating room, seventeen participants who underwent a neurosurgical biopsy with the StealthStation S8 were included. Prior to the clinical procedure, our proposed markerless AR system provided an automated three-dimensional virtual overlay onto the patient to the surgeon. By measuring the difference in the planned biopsy trajectory between the state-of-the-art StealthStation S8 and our experimental system, a comparison was made between the two systems.
resultsThe average clinical error for the entry point of the proposed system was 4.5 ± 2.2 mm, which is lower than the total error of the current clinical gold standard found in literature.
conclusionThe total error of the system proposed in this study reaches the gold standard for image-guided neuronavigation, in both lab-controlled and clinical settings. These initial results highlight the potential and advantages of AR over other methods, offering promising AR opportunities for future clinical applications.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.